Contact Lens Spectrum

January 2007

Document #134




(p. 19) Prescribing for Presbyopia: Is the Time for Monovision Over? By Craig W. Norman, FCLSA


  1. Richdale et al. Comparison of multifocal and monovision soft contact lens corrections in low-astigmatic presbyopic patients. Optom & Vis Sci. May 2006.



(p. 21) GP Insights: GPs and Myopia Progression, By Marjorie Rah, OD, PhD, FAAO


Khoo CY, Chong J, Rajan U. A 3-year study on the effect of RGP contact lenses on myopic children. Singapore Med J. Apr 1999;40(4):230-237.

2.         Perrigin J, Perrigin D, Quintero S, Grosvenor T. Silicone-acrylate contact lenses for myopia control: 3-year results. Optom Vis Sci. Oct 1990;67(10):764-769.

3.         Walline JJ, Jones LA, Mutti DO, Zadnik K. A randomized trial of the effects of rigid contact lenses on myopia progression. Arch Ophthalmol. Dec 2004;122(12):1760-1766.

4.         Katz J, Schein OD, Levy B, et al. A randomized trial of rigid gas permeable contact lenses to reduce progression of children's myopia. Am J Ophthalmol. Jul 2003;136(1):82-90.

5.         Reim T, Lund M, Wu R. Orthokeratology and adolescent myopia control. CL Spectrum. 2003;18(3).

6.         Cho P, Cheung S, Edwards M. The Longitudinal Orthokeratology Research in Children (LORIC) in Hong Kong: A pilot study on refractive changes and myopic control. Current Eye Research. 2005;30:71-80.




(p. 22) Contact Lens Materials: A Look at Lubricating Agents in Daily Disposables, by Jason J. Nichols, OD, MPH, PhD








(p. 23) Dry Eye Dx and Tx: Eyelid Transillumination, By William Townsend, OD


  1. Jester JV, Rife L, Nii D, Luttrull JK, Wilson L, Smith RE.  In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1982 May;22(5):660-7.


  1. Robin JB, Jester JV, Nobe J, Nicolaides N, Smith RE. In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. A clinical study. Ophthalmology. 1985 Oct;92(10):1423-6.




(p. 34) International Contact Lens Prescribing in 2006, By Philip Morgan, PhD, MCOptom, FAAO, FBCLA, et al


  1. Morgan PB, Efron N, Woods CA, Jones D, Tranoudis I, van der Worp E, Helland M.  International contact lens prescribing  Contact Lens Spectrum 2002; 17(1): 42-45.
  2. Morgan PB, Efron N, Woods CA, Jones D, Tranoudis I, van der Worp E, Helland M, Barr J and Bailey G.  International contact lens prescribing  Contact Lens Spectrum 2003; 18(1): 32-35.
  3. Morgan PB, Efron N, Woods CA, Jones D, Tranoudis I, Itoi M, van der Worp E, Helland M, Hong AYC, Barr JT.  International contact lens prescribing in 2003.  Contact Lens Spectrum 2004; 19(1): 34-37.
  4. Morgan PB, Efron N, Woods CA, Jones D, Grein H-J, Tranoudis IG, Montani G, Marani E, Itoi M, van der Worp E, Phillips G, Helland M, Thunholm-Henriksson I-L, Hong AYC, Barr JT.  International contact lens prescribing in 2004.  Contact Lens Spectrum 2005; 20(1): 34-37.
  5. Morgan PB, Efron N, Woods CA, Jones D, Pesinova A, Grein H-J, Tranoudis IG, Chandrinos A, Itoi M, van der Worp E, Phillips G, Belousov V, Helland M, Thunholm-Henriksson I-L, Ong A, Lee KH, Barr JT.  International contact lens prescribing in 2005.  Contact Lens Spectrum 2006; 21(1): 35-39.




(p. 39) Toric Lenses, Gravity and Other Forces, By Graeme Young, MPhil, PhD, FCOptom, DCLP, FAAO


1.                   Hanks AJ.  The watermelon seed principle. Cont lens Forum 1983; 8(9):31-35.

2.                   Doane MG. Blinking and the mechanisms of the lacrimal drainage system. Am J Ophthal 1981; 88: 844-850.

3.                   Young G. Toric contact lens designs in hyper-O2 materials.  CLAO J 2003; 29:S171-173.

4.                   Young G, Hunt C, Covey M. Clinical evaluation of factors influencing toric soft contact lens fit.  Optom Vis Sci 2002; 79:11-19.

5.                   Young G, Hickson-Curran S.  Reassessing toric soft lens fitting. CL Spectrum 2005; 20(1):42-45.




(p. 39) A Personalized Contact Lens Prescription, By P. Douglas Becherer, OD, FAAO, Robert L. Davis, OD, FAAO and Jeffrey A. Kempf, OD


1.  Andre M, Davis J, Caroline P, “A New Approach to Fitting Soft Contact Lenses.” Eyewitness,  Fourth Quarter, 2001.

2.  Douthwaite WA, “Initial Selection of Soft Contact Lenses Based on Corneal Characteristics.” CLAO J. 2002; 28(4):202-5.



(p. 48) Contact Lens Practice Pearls: The Role of Ocular Dominance in Presbyopic Lens Correction, By Thomas G. Quinn, OD, MS, FAAO


  1. Collins MJ, Goode A, Interocular blur suppression and monovision, Acta Ophthalmol (Copenh) 1994; 72(3):376-80.


  1. Handa t, Shimizu K, Mukuno K, Kawamorita T, Uozato H, Effects of ocular dominance on binocular summation after monocular reading adds, J Catract Refract Surg 2005; 31(8):1588-92.


  1. Robboy MW, Cox IG, Erickson P, Effects of sighting and sensory dominance on monovsion hight and low contrast  visual acuity, CLAO J. 1990 Oct-Dec; 16(4):299-301.


  1. Shor C, Landsman L, Erickson P, Ocular dominance and the interocular suppression of blur in monovision, Am J Optom Physiol Opt. 1987 Oct; 64(10):723-30.



(p. 50) Treatment Plan: OHT — To Treat or Not to Treat, By Leo Semes, OD, FAAO


1. Mansberger SL. A risk calculator to determine the probability of glaucoma. J Glaucoma. 2004; 13: 345-7.


2. Medeiros FA, Weinreb RN, Sample PA, Gomi CF, Bowd C, Crowston JG, Zangwill LM. Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol. 2005; 123: 1351-60.


3. Brandt JD, Beiser JA, Gordon MO, Kass MA; Ocular Hypertension Treatment Study (OHTS) Group. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004; 138: 717-22. 


4. Takahashi I, Tanaka M. Switching to latanoprost monotherapy for 24 weeks in glaucoma patients. Eur J Ophthalmol. 2004; 14: 401-6.


5. Ito K, Goto R, Matsunaga K, Sugimoto K, Uji Y. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension. Jpn J Ophthalmol. 2004; 48: 276-80.


6. Pillunat LE, Larsson LI; European and Canadian Latanoprost Study Group. Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

Br J Ophthalmol. 2003; 87: 1492-6.


7. Mansberger SL, Cioffi GA. The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator.

J Glaucoma. 2006; 15: 426-31.